Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Impact of a pharmacist-led education and follow-up service on anticoagulation control and safety outcomes at a tertiary hospital in China: a randomised controlled trial.

Liang JB, Lao CK, Tian L, Yang YY, Wu HM, Tong HH, Chan A.

Int J Pharm Pract. 2019 Oct 1. doi: 10.1111/ijpp.12584. [Epub ahead of print]

PMID:
31576625
2.

X-Ray Diffraction and Theoretical Calculation-Supported Formation of Polymorphic Cocrystals Discovered Through Thermal Methods: A Case Study.

Zhou Z, Calatayud M, Contreras-García J, Li L, Tong HHY, Zheng Y.

J Pharm Sci. 2019 Oct;108(10):3340-3347. doi: 10.1016/j.xphs.2019.05.019. Epub 2019 May 28.

PMID:
31145922
3.

Comparison of normal versus imiquimod-induced psoriatic skin in mice for penetration of drugs and nanoparticles.

Sun L, Liu Z, Lin Z, Cun D, Tong HH, Yan R, Wang R, Zheng Y.

Int J Nanomedicine. 2018 Sep 21;13:5625-5635. doi: 10.2147/IJN.S170832. eCollection 2018.

4.

VariFunNet, an integrated multiscale modeling framework to study the effects of rare non-coding variants in Genome-Wide Association Studies: applied to Alzheimer's Disease.

Liu Q, Chen C, Gao A, Tong HH, Xie L; Alzheimer’s Disease Neuroimaging Initiative.

Proceedings (IEEE Int Conf Bioinformatics Biomed). 2017 Nov;2017:2177-2182. doi: 10.1109/BIBM.2017.8217995. Epub 2017 Dec 18.

5.

Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel.

Sun L, Liu Z, Wang L, Cun D, Tong HHY, Yan R, Chen X, Wang R, Zheng Y.

J Control Release. 2017 May 28;254:44-54. doi: 10.1016/j.jconrel.2017.03.385. Epub 2017 Mar 24.

PMID:
28344018
6.

Topical Fish Oil Application Coupling with Therapeutic Ultrasound Improves Tendon Healing.

Chan KO, Tong HH, Ng GY.

Ultrasound Med Biol. 2016 Dec;42(12):2983-2989. doi: 10.1016/j.ultrasmedbio.2016.08.018. Epub 2016 Sep 28.

PMID:
27692307
7.

Resveratrol cocrystals with enhanced solubility and tabletability.

Zhou Z, Li W, Sun WJ, Lu T, Tong HHY, Sun CC, Zheng Y.

Int J Pharm. 2016 Jul 25;509(1-2):391-399. doi: 10.1016/j.ijpharm.2016.06.006. Epub 2016 Jun 6.

PMID:
27282539
8.

Evaluation in vitro and in vivo of curcumin-loaded mPEG-PLA/TPGS mixed micelles for oral administration.

Duan Y, Zhang B, Chu L, Tong HH, Liu W, Zhai G.

Colloids Surf B Biointerfaces. 2016 May 1;141:345-354. doi: 10.1016/j.colsurfb.2016.01.017. Epub 2016 Jan 14.

PMID:
26874910
9.

Identification of New Cocrystal Systems with Stoichiometric Diversity of Salicylic Acid Using Thermal Methods.

Zhou Z, Chan HM, Sung HH, Tong HH, Zheng Y.

Pharm Res. 2016 Apr;33(4):1030-9. doi: 10.1007/s11095-015-1849-1. Epub 2016 Jan 7.

PMID:
26744333
10.

Annexin A2 Enhances Complement Activation by Inhibiting Factor H.

Renner B, Tong HH, Laskowski J, Jonscher K, Goetz L, Woolaver R, Hannan J, Li YX, Hourcade D, Pickering MC, Holers VM, Thurman JM.

J Immunol. 2016 Feb 1;196(3):1355-65. doi: 10.4049/jimmunol.1500793. Epub 2016 Jan 4.

11.

In silico prediction of prostaglandin D2 synthase inhibitors from herbal constituents for the treatment of hair loss.

Fong P, Tong HH, Ng KH, Lao CK, Chong CI, Chao CM.

J Ethnopharmacol. 2015 Dec 4;175:470-80. doi: 10.1016/j.jep.2015.10.005. Epub 2015 Oct 9.

PMID:
26456343
12.

Underdiagnosis of depression in an economically deprived population in Macao, China.

Lao CK, Chan YM, Tong HH, Chan A.

Asia Pac Psychiatry. 2016 Mar;8(1):70-9. doi: 10.1111/appy.12208. Epub 2015 Aug 21.

PMID:
26293902
13.

Application of nano- and micro-particles on the topical therapy of skin-related immune disorders.

Sun L, Liu Z, Cun D, Tong HH, Zheng Y.

Curr Pharm Des. 2015;21(19):2643-67. Review.

PMID:
25876913
14.

Exposure to selective serotonin reuptake inhibitors during pregnancy and risk of autism spectrum disorder in children: a systematic review and meta-analysis of observational studies.

Man KK, Tong HH, Wong LY, Chan EW, Simonoff E, Wong IC.

Neurosci Biobehav Rev. 2015 Feb;49:82-9. doi: 10.1016/j.neubiorev.2014.11.020. Epub 2014 Dec 9. Review.

PMID:
25498856
15.

Mapping refuse profile in Singapore old dumping ground through electrical resistivity, S-wave velocity and geotechnical monitoring.

Yin K, Tong HH, Noh O, Wang JY, Giannis A.

Bull Environ Contam Toxicol. 2015 Mar;94(3):275-81. doi: 10.1007/s00128-014-1427-y. Epub 2014 Nov 27.

PMID:
25427774
16.

Deletion of the complement C5a receptor alleviates the severity of acute pneumococcal otitis media following influenza A virus infection in mice.

Tong HH, Lambert G, Li YX, Thurman JM, Stahl GL, Douthitt K, Clancy C, He Y, Bowman AS.

PLoS One. 2014 Apr 16;9(4):e95160. doi: 10.1371/journal.pone.0095160. eCollection 2014.

17.

In silico prediction of tyrosinase and adenylyl cyclase inhibitors from natural compounds.

Fong P, Tong HH, Chao CM.

Nat Prod Commun. 2014 Feb;9(2):189-94.

PMID:
24689287
18.

Potentially inappropriate prescribing and drug-drug interactions among elderly Chinese nursing home residents in Macao.

Lao CK, Ho SC, Chan KK, Tou CF, Tong HH, Chan A.

Int J Clin Pharm. 2013 Oct;35(5):805-12. doi: 10.1007/s11096-013-9811-y. Epub 2013 Jun 28.

PMID:
23812679
19.

Complement activation in pediatric patients with recurrent acute otitis media.

He Y, Scholes MA, Wiet GJ, Li Q, Clancy C, Tong HH.

Int J Pediatr Otorhinolaryngol. 2013 Jun;77(6):911-7. doi: 10.1016/j.ijporl.2013.03.004. Epub 2013 Mar 26.

20.
21.

Role of the alternative and classical complement activation pathway in complement mediated killing against Streptococcus pneumoniae colony opacity variants during acute pneumococcal otitis media in mice.

Li Q, Li YX, Douthitt K, Stahl GL, Thurman JM, Tong HH.

Microbes Infect. 2012 Nov;14(14):1308-18. doi: 10.1016/j.micinf.2012.08.002. Epub 2012 Aug 30.

22.

Challenges for accurate and prompt molecular diagnosis of clades of highly pathogenic avian influenza H5N1 viruses emerging in Vietnam.

Slomka MJ, To TL, Tong HH, Coward VJ, Hanna A, Shell W, Pavlidis T, Densham AL, Kargiolakis G, Arnold ME, Banks J, Brown IH.

Avian Pathol. 2012;41(2):177-93. doi: 10.1080/03079457.2012.656578.

PMID:
22515536
23.

Evaluation of lateral flow devices for identification of infected poultry by testing swab and feather specimens during H5N1 highly pathogenic avian influenza outbreaks in Vietnam.

Slomka MJ, To TL, Tong HH, Coward VJ, Mawhinney IC, Banks J, Brown IH.

Influenza Other Respir Viruses. 2012 Sep;6(5):318-27. doi: 10.1111/j.1750-2659.2011.00317.x. Epub 2011 Dec 12.

24.

Essential role of factor B of the alternative complement pathway in complement activation and opsonophagocytosis during acute pneumococcal otitis media in mice.

Li Q, Li YX, Stahl GL, Thurman JM, He Y, Tong HH.

Infect Immun. 2011 Jul;79(7):2578-85. doi: 10.1128/IAI.00168-11. Epub 2011 Apr 18.

25.
26.

Spray freeze drying with polyvinylpyrrolidone and sodium caprate for improved dissolution and oral bioavailability of oleanolic acid, a BCS Class IV compound.

Tong HH, Du Z, Wang GN, Chan HM, Chang Q, Lai LC, Chow AH, Zheng Y.

Int J Pharm. 2011 Feb 14;404(1-2):148-58. doi: 10.1016/j.ijpharm.2010.11.027. Epub 2010 Nov 19.

PMID:
21094233
27.

Caffeine as a photoprotective agent for diminishing phototoxicity.

Szeto YT, Tong HH.

Toxicol Ind Health. 2010 Nov;26(10):667-70. doi: 10.1177/0748233710375947. Epub 2010 Jul 14.

PMID:
20630985
28.

Evaluation of extemporaneous oral itraconazole suspensions by dissolution profiles mapping.

Tong HH, Chan H, Du Z, Zheng Y.

Int J Pharm Compd. 2010 Jul-Aug;14(4):342-5.

PMID:
23965542
29.

Enhanced susceptibility to acute pneumococcal otitis media in mice deficient in complement C1qa, factor B, and factor B/C2.

Tong HH, Li YX, Stahl GL, Thurman JM.

Infect Immun. 2010 Mar;78(3):976-83. doi: 10.1128/IAI.01012-09. Epub 2010 Jan 11.

30.

Process-induced phase transformation of berberine chloride hydrates.

Tong HH, Chow AS, Chan HM, Chow AH, Wan YK, Williams ID, Shek FL, Chan CK.

J Pharm Sci. 2010 Apr;99(4):1942-54. doi: 10.1002/jps.21983.

PMID:
19894277
31.

Formulation development and bioavailability evaluation of a self-nanoemulsified drug delivery system of oleanolic acid.

Xi J, Chang Q, Chan CK, Meng ZY, Wang GN, Sun JB, Wang YT, Tong HH, Zheng Y.

AAPS PharmSciTech. 2009;10(1):172-82. doi: 10.1208/s12249-009-9190-9. Epub 2009 Feb 18.

32.

Anti-hygroscopic effect of dextrans in herbal formulations.

Tong HH, Wong SY, Law MW, Chu KK, Chow AH.

Int J Pharm. 2008 Nov 3;363(1-2):99-105. doi: 10.1016/j.ijpharm.2008.07.016. Epub 2008 Jul 25.

PMID:
18706495
33.

Differential expression of cytokine genes and iNOS induced by nonviable nontypeable Haemophilus influenzae or its LOS mutants during acute otitis media in the rat.

Tong HH, Chen Y, Liu X, DeMaria TF.

Int J Pediatr Otorhinolaryngol. 2008 Aug;72(8):1183-91. doi: 10.1016/j.ijporl.2008.04.007. Epub 2008 Jun 3.

34.

Physical characterization of oleanolic acid nonsolvate and solvates prepared by solvent recrystallization.

Tong HH, Wu HB, Zheng Y, Xi J, Chow AH, Chan CK.

Int J Pharm. 2008 May 1;355(1-2):195-202. doi: 10.1016/j.ijpharm.2007.12.005. Epub 2007 Dec 15.

PMID:
18207676
35.

Engineering of pharmaceutical materials: an industrial perspective.

Chow K, Tong HH, Lum S, Chow AH.

J Pharm Sci. 2008 Aug;97(8):2855-77. Review.

PMID:
17943933
36.
37.

Structure and drug release in a crosslinked poly(ethylene oxide) hydrogel.

Shekunov BY, Chattopadhyay P, Tong HH, Chow AH, Grossmann JG.

J Pharm Sci. 2007 May;96(5):1320-30.

PMID:
17455363
38.

Particle engineering for pulmonary drug delivery.

Chow AH, Tong HH, Chattopadhyay P, Shekunov BY.

Pharm Res. 2007 Mar;24(3):411-37. Review.

PMID:
17245651
39.

Particle size analysis in pharmaceutics: principles, methods and applications.

Shekunov BY, Chattopadhyay P, Tong HH, Chow AH.

Pharm Res. 2007 Feb;24(2):203-27. Epub 2006 Dec 27. Review.

PMID:
17191094
40.

Identification of related QTLs at late developmental stage in rice (Oryza sativa L.) under two nitrogen levels.

Tong HH, Mei HW, Yu XQ, Xu XY, Li MS, Zhang SQ, Luo LJ.

Yi Chuan Xue Bao. 2006 May;33(5):458-67.

PMID:
16722341
41.
42.

Sortase A contributes to pneumococcal nasopharyngeal colonization in the chinchilla model.

Chen S, Paterson GK, Tong HH, Mitchell TJ, DeMaria TF.

FEMS Microbiol Lett. 2005 Dec 1;253(1):151-4. Epub 2005 Oct 13.

43.
44.

Effect of amino acids on the dispersion of disodium cromoglycate powders.

Chew NY, Shekunov BY, Tong HH, Chow AH, Savage C, Wu J, Chan HK.

J Pharm Sci. 2005 Oct;94(10):2289-300.

PMID:
16136546
45.

An improved thermoanalytical approach to quantifying trace levels of polymorphic impurity in drug powders.

Tong HH, Shekunov BY, Chan JP, Mok CK, Hung HC, Chow AH.

Int J Pharm. 2005 May 13;295(1-2):191-9.

PMID:
15848004
46.

Surface characterization of salmeterol xinafoate powders by inverse gas chromatography at finite coverage.

Tong HH, Shekunov BY, York P, Chow AH.

J Pharm Sci. 2005 Mar;94(3):695-700.

PMID:
15668948
47.

Stability of extemporaneous oral ribavirin liquid preparation.

Chan JP, Tong HH, Chow AH.

Int J Pharm Compd. 2004 Nov-Dec;8(6):486-8.

PMID:
23924816
48.

Use of inverse gas chromatography (IGC) to determine the surface energy and surface area of powdered materials.

Chow AH, Tong HH, Shekunov BY, York P.

Pharm Res. 2004 Sep;21(9):1718-9; author reply 1719-20. No abstract available.

PMID:
15497701

Supplemental Content

Support Center